caa a22 4500 445807296 CHVBK 20180317145200.0 cr unu---uuuuu 170323e20110101xx s 000 0 eng 10.1007/s00415-010-5746-6 doi (NATIONALLICENCE)springer-10.1007/s00415-010-5746-6 Argov Zohar Department of Neurology, Hadassah-Hebrew University Medical Center, Jerusalem, Israel aut Current approach to seronegative myasthenia [Elektronische Daten] [Zohar Argov] The group of patients with weakness or fatigue who have electrophysiological evidence of neuromuscular transmission defects, but no antibodies against either acetyl choline receptor or muscle specific kinase, need special evaluation and therapeutic consideration. Such seronegative patients may have low affinity antibodies but may also be late onset of a congenital myasthenic syndrome. This review discuss the practical approach toward the condition of seronegative myasthenia. Springer-Verlag, 2010 Myasthenia nationallicence Congenital myasthenic syndrome nationallicence Repetitive nerve stimulation nationallicence Acetyl choline receptor antibodies nationallicence Journal of Neurology Springer-Verlag 258/1(2011-01-01), 14-18 0340-5354 258:1<14 2011 258 415 https://doi.org/10.1007/s00415-010-5746-6 text/html Onlinezugriff via DOI 1 review-article jats NATIONALLICENCE 856 40 https://doi.org/10.1007/s00415-010-5746-6 text/html Onlinezugriff via DOI NATIONALLICENCE 100 1- Argov Zohar Department of Neurology, Hadassah-Hebrew University Medical Center, Jerusalem, Israel aut NATIONALLICENCE 773 0- Journal of Neurology Springer-Verlag 258/1(2011-01-01), 14-18 0340-5354 258:1<14 2011 258 415 Metadata rights reserved Springer special CC-BY-NC licence nationallicence BK010053 XK010053 XK010000 NATIONALLICENCE NATIONALLICENCE NL-springer